New Antibiotic Zosurabalpin Shows Promise Against Drug-Resistant Bacteria
The novel antibiotic, currently in Phase I trials, effectively kills Acinetobacter baumannii, a bacteria resistant to most current antibiotics and a significant cause of hospital infections.
